News & Analysis on Clinical Trial Services & Contract Research And Development
Belgium-based biopharmaceutical company, ThromboGenics, has signed a ten-year supply agreement with MSD Biologics, to produce microplasmin for the treatment of retinal disorders.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Oso BioPharmaceuticals, Creabilis SA and Clondalkin.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Kendle, INC, AAIPharma and ClinTec.
RXi and EyeGate lift the lid on ocular delivery of RNAi therapeutics for retinal disorders as the two firm’s team up to provide a unique needle-free solution.
Precos is aiming to accelerate growth of its attrition-reducing preclinical oncology screening services by naming a co-founder of ClinPhone as chairman.
Gilead Sciences has received a warning letter from the US Food and Drug Administration (FDA) concerning manufacturing problems at the San Dimas, California, plant, where HIV medicines are made.
Drug discovery and development company, BioRelix, are collaborating with a subsidiary of Merck to indentify new antibacterial drug candidates.